1-13 of 13
Mark S. Cragg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Development of C1q Affinity Chromatography for the Study of C1q–IgG Interactions

Michael J. E. Marshall, Alexander Knaupp, Christian Spick, Ilker Koese, Maria Maier, Mark S. Cragg, Florian Cymer, Tilman Schlothauer
Journal: The Journal of Immunology
J Immunol (2023) 210 (11): 1837–1848.
https://doi.org/10.4049/jimmunol.2100370
Published: 24 April 2023
View article titled, Development of C1q Affinity Chromatography for the Study of C1q–IgG Interactions
Open the PDF for Development of C1q Affinity Chromatography for the Study of C1q–IgG Interactions in another window
Add to Citation Manager
Includes: Supplementary data
Journal Articles

KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity

Matthew D. Blunt, Andres Vallejo Pulido, Jack G. Fisher, Lara V. Graham, Amber D. P. Doyle, Rebecca Fulton, Matthew J. Carter, Marta Polak, Peter W. M. Johnson, Mark S. Cragg, Francesco Forconi, Salim I. Khakoo
Journal: The Journal of Immunology
J Immunol (2022) 209 (2): 379–390.
https://doi.org/10.4049/jimmunol.2101139
Published: 15 July 2022
View article titled, KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity
Open the PDF for KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity in another window
Add to Citation Manager
Includes: Supplementary data
Journal Articles

The PI3Kδ-Selective Inhibitor Idelalisib Minimally Interferes with Immune Effector Function Mediated by Rituximab or Obinutuzumab and Significantly Augments B Cell Depletion In Vivo

Adam Palazzo, Sylvia Herter, Laura Grosmaire, Randy Jones, Christian R. Frey, Florian Limani, Marina Bacac, Pablo Umana, Robert J. Oldham, Michael J. E. Marshall, Kerry L. Cox, Anna H. Turaj, Mark S. Cragg, Christian Klein, Matthew J. Carter, Stacey Tannheimer
Journal: The Journal of Immunology
J Immunol (2018) 200 (7): 2304–2312.
https://doi.org/10.4049/jimmunol.1700323
Published: 01 April 2018
View article titled, The PI3Kδ-Selective Inhibitor Idelalisib Minimally Interferes with Immune Effector Function Mediated by Rituximab or Obinutuzumab and Significantly Augments B Cell Depletion In Vivo
Open the PDF for The PI3Kδ-Selective Inhibitor Idelalisib Minimally Interferes with Immune Effector Function Mediated by Rituximab or Obinutuzumab and Significantly Augments B Cell Depletion In Vivo in another window
Add to Citation Manager
Includes: Supplementary data
Journal Articles

Detection of Experimental and Clinical Immune Complexes by Measuring SHIP-1 Recruitment to the Inhibitory FcγRIIB

Richard J. Stopforth, Robert J. Oldham, Alison L. Tutt, Patrick Duriez, H. T. Claude Chan, Brock F. Binkowski, Chad Zimprich, Dun Li, Philip G. Hargreaves, Mei Cong, Venkat Reddy, Maria J. Leandro, Geraldine Cambridge, Anja Lux, Falk Nimmerjahn, Mark S. Cragg
Journal: The Journal of Immunology
J Immunol (2018) 200 (5): 1937–1950.
https://doi.org/10.4049/jimmunol.1700832
Published: 01 March 2018
View article titled, Detection of Experimental and Clinical Immune Complexes by Measuring SHIP-1 Recruitment to the Inhibitory FcγRIIB
Open the PDF for Detection of Experimental and Clinical Immune Complexes by Measuring SHIP-1 Recruitment to the Inhibitory FcγRIIB in another window
Add to Citation Manager
Includes: Multimedia, Supplementary data
Journal Articles

Antibody Distance from the Cell Membrane Regulates Antibody Effector Mechanisms

Kirstie L. S. Cleary, H. T. Claude Chan, Sonja James, Martin J. Glennie, Mark S. Cragg
Journal: The Journal of Immunology
J Immunol (2017) 198 (10): 3999–4011.
https://doi.org/10.4049/jimmunol.1601473
Published: 15 May 2017
View article titled, Antibody Distance from the Cell Membrane Regulates Antibody Effector Mechanisms
Open the PDF for Antibody Distance from the Cell Membrane Regulates Antibody Effector Mechanisms in another window
Add to Citation Manager
Includes: Supplementary data
Journal Articles

Polymorphisms in FcγRII (CD32) mediate abnormal antibody half-life in NOD SCID mice and reduce antibody-mediated tumour cell deletion.

Robert J Oldham, Kerry L Cox, Mark S Cragg
Journal: The Journal of Immunology
J Immunol (2017) 198 (1_Supplement): 222.21.
https://doi.org/10.4049/jimmunol.198.Supp.222.21
Published: 01 May 2017
View article titled, Polymorphisms in FcγRII (CD32) mediate abnormal antibody half-life in NOD SCID mice and reduce antibody-mediated tumour cell deletion.
Add to Citation Manager
Journal Articles

FcγRIIB-Independent Mechanisms Controlling Membrane Localization of the Inhibitory Phosphatase SHIP in Human B Cells

Samantha D. Pauls, Arnab Ray, Sen Hou, Andrew T. Vaughan, Mark S. Cragg, Aaron J. Marshall
Journal: The Journal of Immunology
J Immunol (2016) 197 (5): 1587–1596.
https://doi.org/10.4049/jimmunol.1600105
Published: 01 September 2016
View article titled, FcγRIIB-Independent Mechanisms Controlling Membrane Localization of the Inhibitory Phosphatase SHIP in Human B Cells
Open the PDF for FcγRIIB-Independent Mechanisms Controlling Membrane Localization of the Inhibitory Phosphatase SHIP in Human B Cells in another window
Add to Citation Manager
Includes: Supplementary data
Journal Articles

Development and Characterization of Monoclonal Antibodies Specific for Mouse and Human Fcγ Receptors

Alison L. Tutt, Sonya James, Stéphanie A. Laversin, Thomas R. W. Tipton, Margaret Ashton-Key, Ruth R. French, Khiyam Hussain, Andrew T. Vaughan, Lang Dou, Alexander Earley, Lekh N. Dahal, Chen Lu, Melanie Dunscombe, H. T. Claude Chan, Christine A. Penfold, Jinny H. Kim, Elizabeth A. Potter, C. Ian Mockridge, Ali Roghanian, Robert J. Oldham, Kerry L. Cox, Sean H. Lim, Ingrid Teige, Bjorn Frendéus, Martin J. Glennie, Stephen A. Beers, Mark S. Cragg
Journal: The Journal of Immunology
J Immunol (2015) 195 (11): 5503–5516.
https://doi.org/10.4049/jimmunol.1402988
Published: 01 December 2015
View article titled, Development and Characterization of Monoclonal Antibodies Specific for Mouse and Human Fcγ Receptors
Open the PDF for Development and Characterization of Monoclonal Antibodies Specific for Mouse and Human Fcγ Receptors in another window
Add to Citation Manager
Includes: Supplementary data
Journal Articles

Fcγ Receptor Dependency of Agonistic CD40 Antibody in Lymphoma Therapy Can Be Overcome through Antibody Multimerization

Ann L. White, Lang Dou, H. T. Claude Chan, Vikki L. Field, C. Ian Mockridge, Kane Moss, Emily L. Williams, Steven G. Booth, Ruth R. French, Elizabeth A. Potter, Cherié Butts, Aymen Al-Shamkhani, Mark S. Cragg, J. Sjef Verbeek, Peter W. M. Johnson, Martin J. Glennie, Stephen A. Beers
Journal: The Journal of Immunology
J Immunol (2014) 193 (4): 1828–1835.
https://doi.org/10.4049/jimmunol.1303204
Published: 15 August 2014
View article titled, Fcγ Receptor Dependency of Agonistic CD40 Antibody in Lymphoma Therapy Can Be Overcome through Antibody Multimerization
Open the PDF for Fcγ Receptor Dependency of Agonistic CD40 Antibody in Lymphoma Therapy Can Be Overcome through Antibody Multimerization in another window
Add to Citation Manager
Journal Articles

Immunotherapy Targeting Inhibitory Fcγ Receptor IIB (CD32b) in the Mouse Is Limited by Monoclonal Antibody Consumption and Receptor Internalization

Emily L. Williams, Alison L. Tutt, Stephen A. Beers, Ruth R. French, Claude H. T. Chan, Kerry L. Cox, Ali Roghanian, Christine A. Penfold, Cherié L. Butts, Peter Boross, J. Sjef Verbeek, Mark S. Cragg, Martin J. Glennie
Journal: The Journal of Immunology
J Immunol (2013) 191 (8): 4130–4140.
https://doi.org/10.4049/jimmunol.1301430
Published: 15 October 2013
View article titled, Immunotherapy Targeting Inhibitory Fcγ Receptor IIB (CD32b) in the Mouse Is Limited by Monoclonal Antibody Consumption and Receptor Internalization
Open the PDF for Immunotherapy Targeting Inhibitory Fcγ Receptor IIB (CD32b) in the Mouse Is Limited by Monoclonal Antibody Consumption and Receptor Internalization in another window
Add to Citation Manager
Includes: Supplementary data
Journal Articles

Interaction with FcγRIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody

Ann L. White, H. T. Claude Chan, Ali Roghanian, Ruth R. French, C. Ian Mockridge, Alison L. Tutt, Sandra V. Dixon, Daniel Ajona, J. Sjef Verbeek, Aymen Al-Shamkhani, Mark S. Cragg, Stephen A. Beers, Martin J. Glennie
Journal: The Journal of Immunology
J Immunol (2011) 187 (4): 1754–1763.
https://doi.org/10.4049/jimmunol.1101135
Published: 15 August 2011
View article titled, Interaction with FcγRIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody
Open the PDF for Interaction with FcγRIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody in another window
Add to Citation Manager
Journal Articles

Systemic Inflammation Modulates Fc Receptor Expression on Microglia during Chronic Neurodegeneration

Katie Lunnon, Jessica L. Teeling, Alison L. Tutt, Mark S. Cragg, Martin J. Glennie, V. Hugh Perry
Journal: The Journal of Immunology
J Immunol (2011) 186 (12): 7215–7224.
https://doi.org/10.4049/jimmunol.0903833
Published: 15 June 2011
View article titled, Systemic Inflammation Modulates Fc Receptor Expression on Microglia during Chronic Neurodegeneration
Open the PDF for Systemic Inflammation Modulates Fc Receptor Expression on Microglia during Chronic Neurodegeneration in another window
Add to Citation Manager
Journal Articles

Functional Analysis of HIV Type 1 Nef Reveals a Role for PAK2 as a Regulator of Cell Phenotype and Function in the Murine Dendritic Cell Line, DC2.4

Jelena Mann, Claire N. Patrick, Mark S. Cragg, Jamie Honeychurch, Derek A. Mann, Mark Harris
Journal: The Journal of Immunology
J Immunol (2005) 175 (10): 6560–6569.
https://doi.org/10.4049/jimmunol.175.10.6560
Published: 15 November 2005
View article titled, Functional Analysis of HIV Type 1 Nef Reveals a Role for PAK2 as a Regulator of Cell Phenotype and Function in the Murine Dendritic Cell Line, DC2.4
Open the PDF for Functional Analysis of HIV Type 1 Nef Reveals a Role for PAK2 as a Regulator of Cell Phenotype and Function in the Murine Dendritic Cell Line, DC2.4 in another window
Add to Citation Manager